RxDoctor Payments DataLook up a doctor →

Mel Roca, MD

Family Medicine · Council Bluffs, IANPI 1841427564

Payments from drug & device makers

$13,192in general payments, 2019–2025

Across 765 payments — averaging $17.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$1K
  • Novo Nordisk$1K
  • Aimmune Therapeutics, Inc.$777
  • Pfizer$751
  • Amgen$738
  • plus $6K from 51 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)123$2,463
AstraZeneca51$1,279
Novo Nordisk75$1,154
Aimmune Therapeutics, Inc.7$777
Pfizer64$751
Amgen59$738
Lilly USA, LLC56$669
GSK47$627
Bayer30$610
Gilead15$340
Boehringer Ingelheim24$301
Novartis19$271
Johnson & Johnson20$268
Teva Pharmaceuticals USA, Inc.13$225
Astellas Pharma US Inc15$223
Nestle Healthcare Nutrition Inc.4$216
Sanofi-aventis U.S. LLC12$206
Otsuka America Pharmaceutical, Inc.13$195
Abbott11$189
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)9$154
Medtronic1$125
Sumitomo Pharma America, Inc.5$90
Takeda Pharmaceuticals U.S.A., Inc.7$86
Ironwood Pharmaceuticals, Inc5$82
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC5$73
Vertex4$72
E.r. Squibb & Sons, L.L.C.5$69
Merck5$68
Sunovion Pharmaceuticals Inc.7$62
Insulet Corporation4$60
Lundbeck LLC4$59
Corcept Therapeutics4$57
Biohaven Pharmaceutical Holding Company Ltd.4$55
Kowa Pharmaceuticals America, Inc.4$52
Vanda Pharmaceuticals Inc.2$45
Amarin Pharma, Inc.3$45
Exact Sciences3$43
Genentech USA, Inc.3$40
Lexicon Pharmaceuticals, Inc.2$33
Tonix Medicines, Inc.1$33
Mylan Specialty L.p.2$27
Mannkind Corporation2$24
Regeneron Healthcare Solutions, Inc.2$24
ANI Pharmaceuticals, Inc.1$20
Ironshore Pharmaceuticals Inc.1$20
Neos Therapeutics, LP1$19
Abiomed1$19
Ultragenyx Pharmaceutical Inc.1$17
Biohaven Pharmaceuticals, Inc.1$15
Avanir Pharmaceuticals, Inc.1$15
Acadia Pharmaceuticals Inc1$14
Esperion Therapeutics, Inc.1$14
Organon1$13
Shire North American Group Inc1$13
Eisai Inc.1$12
Dexcom, Inc.1$12
Scilex Pharmaceuticals Inc.1$11

How this compares

$13,192 in reported general payments places this provider in the 95th percentile of 1,357 family medicine providers in Iowa.

See all family medicine providers in Iowa →

Medicare billing

Part B allowed, 2024
$134,431
Medicare patients
305
Services billed
2,423

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Council Bluffs

See the full list for Iowa →

Where these figures come from

Is this you, or does something look wrong? →